Capricor Therapeutics to Present Second Quarter 2020 Financial Results and Recent Corporate Update on August 6
LOS ANGELES, July 30, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) a clinical-stage biotechnology company focused on the development […]